Anemia is a common condition in premature infants, particularly those at risk for retinopathy of prematurity (ROP). While the ...
In 2019, ROP affected 27,000 premature neonates in the US and is a leading cause of childhood blindness. Laser photocoagulation and anti-VEGF [vascular endothelial growth factor] therapy - the two ...
The ability of tumours to induce new blood-vessel formation has been a major focus of cancer research over the past few decades, and vascular endothelial growth factor (VEGF) is now known to be ...
These components help combat oxidative stress and regulate vascular endothelial growth factor (VEGF), a protein implicated in the pathogenesis of ROP. By mitigating oxidative damage and supporting ...
AGE, advanced glycation end product; PDGF, platelet-derived growth factor; ROP, retinopathy of prematurity; ROS, reactive oxygen species; VEGF, vascular endothelial growth factor. Hans-Peter ...